Lung Center of the Philippines Scientific Proceedings
The Lung Center of the Philippines Scientific Proceedings, (Online ISSN 3082-5245 |Print ISSN 0117-9322) the official journal of the Lung Center of the Philippines, is an open-access, English language, medical science journal, published biannually by the Lung Center of the Philippines. The journal intends to share local relevant scientific findings in the field of respiratory medicine through publication of high quality original clinical investigations, epidemiological studies, case reports, review articles, evaluations of diagnostic and surgical techniques, and the latest updates on management guidelines. The journal's target audience are clinicians, surgeons, specialists, laboratorians, scientists, and researchers working on pulmonary medicine. The Lung Center of the Philippines Scientific Proceedings does not charge any subscription, review, or manuscript processing fees.
The Lung Center of the Philippines Scientific Proceedings is licensed under a Creative Commons Attribution-Non-Commercial 4.0 International license (CC BY-NC 4.0) which allows sharing, copying, and redistributing the material in any medium or format, under strict terms of giving appropriate credit to the authors and this journal, and use for non-commercial purposes.
Abstract Background Lung cancer is the second-most commonly diagnosed malignancy and is also the leading cause of cancer-related deaths. Continuous advancement in diagnostic and treatment modalities aims to improve this trend. Objective To present the demographic and clinical profile, diagnosis, management and in-hospital outcomes of lung cancer patients seen at the Lung Center of the Philippines between 2009 to 2017 Methods This was a retrospective cohort review among all patients with lung cancer registered at the Lung Center of the Philippines between January 1, 2009 to December 31, 2017. The data were extracted from the medical records of lung cancer patients and recorded in the Lung Cancer Registry forms. The data recorded in the Lung Cancer Registry data collection forms were encoded using the EPI INFO data entry. Results A total of 3,969 lung cancer patients were included in the study. The majority were males (65.96%, n=2,618), 60 years old and above (59.01%, n=2,331), came from National Capital Region (45.2%), with a smoking history (63.16%, n=2,507), Stage IV (66%), non-small cell carcinoma (NSCLC) (89.3%, n=3, 586), adenocarcinoma as dominant sub-type (62.7%, n=225), and underwent diagnostic and staging procedures (75.7%) during the year of first admission: Supportive care 56.6%, surgery 17.8%, radiotherapy 5.7%, and chemotherapy 7.5%. Among the patients included in the study, 719 (18.2%) patients had in-hospital deaths during first admission based on hospital records. However, the mortality data among patients whose deaths which may have occurred outside the hospital were not available. Conclusion In this cohort from 2009 to 2017, 3,969 patients with lung cancer were included, similar to the number of patients with lung cancer included in the previous 2000 to 2008 cohort. Majority are caught in their late stage, offered with supportive therapy, and with notable in-hospital mortality on admission.
Copyright (c) 2026 Lung Center of the Philippines Scientific Proceedings https://creativecommons.org/licenses/by-nc/4.0